
Sun Pharma posts Q1 profit of ₹1,444.17 cr.
The Hindu
Sun Pharmaceutical Industries Ltd. reported a consolidated net profit of ₹1,444.17 crore for the first quarter ended June 30. The company had reported a net loss of ₹1,655.60 crore in the year-earli
Sun Pharmaceutical Industries Ltd. reported a consolidated net profit of ₹1,444.17 crore for the first quarter ended June 30. The company had reported a net loss of ₹1,655.60 crore in the year-earlier period. Consolidated sales from operations at ₹9,669.4 crore grew 29% over Q1 last year. India sales at ₹3,308.4 crore grew 39% compared with Q1 last year, while U.S. finished dosage sales grew 35% to $380 million. Emerging markets sales grew 25% to $218 million, while rest of the world sales grew 35% to $ 185 million.More Related News